Team members from Kessler Foundation and Kessler Institute for Rehabilitation, a Select Medical hospital, will participate in an…
PHARMA & CLINICAL TRIALS


Petrovax announced today the positive results from “Long-CoV-III-21,” a randomized, double-blind, placebo-controlled trial evaluating the…
Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today…


Imlunestrant, an investigational next-generation selective estrogen receptor degrader (SERD), improved progression-free survival in patients with…
Investigators identified changes in immune cells that predict patient recovery, pointing to a drug that…


The new effort aims to rapidly transform academic breakthroughs into life-saving therapies for a range…

